Application of genomeceuticals to the molecular and immunological aspects of autism
To access this article, please choose from the options below
PII: S0306-9877(01)91331-3
doi:10.1054/mehy.2001.1331
© 2001 Harcourt Publishers Ltd. All rights reserved.
